期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

CD_(47)与临床疾病相关研究现状及展望 被引量：1

Relationship of CD_(47) and Clinical Diseases in Current and Future Research
下载PDF
导出
摘要 CD47是细胞表面的重要靶点,是现今临床基因靶向治疗研究的焦点之一,本文对CD47及其相关表达进行了简述,并总结了CD47与炎性疾病、骨性疾病及血液性疾病的相关研究现状,旨在帮助临床医务人员对CD47有进一步的了解,为临床疾病的治疗提供一定的依据与方向。 CD47,a key target on cell surface,is one of the hot research topics on gene-targeted therapy.This article discusses the features of CD47,its related expressions,and its relationship with inflammatory disease,bone disease,and hematologic disease.
作者 高树峰 张少容 李黎
机构地区 南昌大学第二附属医院
出处 《中国全科医学》 CAS CSCD 北大核心 2013年第8期952-954,共3页 Chinese General Practice
基金 江西省自然科学基金资助项目(20114BAB205069)
关键词 CD47 基因治疗 靶点 CD47 Gene therapy Target spot
分类号 R730.59 [医药卫生—肿瘤]
  • 相关文献

参考文献29

  • 1Lindberg FP,Lublin DM,Telen MJ. Rh-related antigen CD47 is the signal-transducer integrin-associated protein[J].Journal of Biological Chemistry,1994,(03):1567-1570.
  • 2Carani L,Sollazzo D,Ricci F. The CD47 pathway is deregulated in human immune thrombocytopenia[J].Experimental Hematology,2011,(04):486-494.
  • 3Mette LJ,Eric JB. Dual regulation of SIRPαphosphorylation by integrins and CD47[J].Journal of Biological Chemistry,2007,(33):24219-24230.
  • 4Stefanidakis M,Newton G,Lee WY. Endothelial CD47 interaction with SIRPgamma is required for human T-cell transendothelial migration under shear flow conditions in vitro[J].Blood,2008,(04):1280-1289.doi:10.1182/blood-2008-01-134429.
  • 5Matozaki T,Mumta Y,Okazawa H. Functions and molecular mechanisms of the CD47-SIRP alpha signalling pathway[J].Trends in Cell Biology,2009,(02):72-80.doi:10.1016/j.tcb.2008.12.001.
  • 6Jaiswal S,Jamieson CH,Pang WW. CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis[J].Cell,2009,(02):271-285.
  • 7Latour S,Tanaka H,Demeure C. Bidirectional negative regulation of human T and dendritic cells by CD47 and its cognate receptor signal-regulator protein-alpha:down-regulation of IL-12 responsiveness and inhibition of dendritic cell activation[J].Journal of Immunology,2001,(05):2547-2554.
  • 8Avice MN,Rubio M,Sergerie M. CD47 ligation selectively inhibits the development of human naive T cells into Th1 effectors[J].Journal of Immunology,2000,(08):4624-4631.
  • 9Majetil R,Chao MP,Alizadehl AA. CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells[J].Cell,2009,(02):286-299.
  • 10Chang WT,Huang AW. Alpha-Pal/NRF-1 regulates the promoter of the human integrin-associated protein/CD47 gene[J].Journal of Biological Chemistry,2004,(15):14542-14550.

同被引文献13

  • 1CHAO MP, AUZADEH AA,TANG C, et al. Anti-CD47 anti-body synergizes with rituximab to promote phagocytosis and erad-icate non-Hodgkin lymphoma[J]. Cell, 2010,142(5): 699-713.
  • 2PETTERSEN RD, HESTDAL K, OLAFSEN MK. CD47 signals Tcell death[J]. J Immunol, 1999, 162(12): 7031-7040.
  • 3JAISWAL S, JAMIESON CH, PANG WW, et al. CD47 is up-regulated on circulating hematopoietic stem cells and leukemiacells to avoid phagocytosis[J]. Cell, 2009, 138⑵:271-285.
  • 4CHAO MP, ALIZADEH AA, TANG C,et al. Anti-CD47 anti-body synergizes with rituximab to promote phagocytosis and erad-icate non-Hodgkin Iymphoma[J]. Cell, 2010, 142(5): 699-713.
  • 5WILLINGHAM STEPHEN B, VOLKMER JENS-PETER, GEN-TLES ANDREW J, et al. The CD47-signal regulatory protein al-pha (SIRPa) interaction is a therapeutic target for human solidtumors[J]. PNAS,2012,109(17): 6662-6667.
  • 6CARANI L, SOLLAZZO D, RICCI F, et al. The CD47 pathwayis deregulated in human immune thrombocytopenia[J]. Exp Hema-tol,2011,39(4): 486-494.
  • 7ZALIOVA M, MADZO J,CAHIO G, et al. Revealing the roleof TEL/AML1 for leukemic cell survival by RNAi-mediated si-lencing J]. Leukemia, 2011, 25(2): 313—320.
  • 8LAVENDER JS, KINZELMAN JL. A cross comparison of QPCRto agar-based or defned substrate test methods for the determi-nation of Escherichia coli and enterococci in municipal waterquality monitoring programs[J]. Water Res, 2009,43(19): 4967-4979.
  • 9PFEIFER A, HOFMANN A. Lenti viral transgenesis [J]. MethodsMol Biol, 2009, 530(3): 391-405.
  • 10DISSEN GA, LOMNICZI A, NEFF TL, et al. In vivo manipu-lation of gene expression in non* human primates using lenti viralvectors 0° delivery vehicles[J]. Methods, 2009, 49(1): 70—77.

引证文献1

二级引证文献1

中国全科医学
2013年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部